-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical staff is a high-risk group of new coronary pneumonia .
New Coronary Pneumonia FDA researchers recently announced the effectiveness of the new coronary pneumonia vaccine in the first-line medical care population
This study is a case-control study involving medical staff in 25 states in the United States
The study included 1482 confirmed cases and 3449 control participants
The effectiveness of the BNT162b2 vaccine after partial vaccination was 77.
Changes in protective effect over time after completing the second dose of vaccination
Changes in the protective effect over time after completing the second dose of vaccination Changes in the protective effect over time after completing the second dose of vaccinationIn the real environment of front-line medical care, the effects of BNT162b2 and mRNA-1273 vaccines have been fully verified, and the vaccine effects are not affected by age and race
In the real environment of front-line medical care, the effects of BNT162b2 and mRNA-1273 vaccines have been fully verified, and the vaccine effects are not affected by age and race
Original source:
Tamara Pilishvili et al.
Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel.
Leave a message here